Elise Reuter

O rthopedics firms are shrugging off worries that a new, mandatory Medicare joint replacement model could drive down implant payments.

Cadence, a company that makes AI-enabled software to support hypertension management, will join the pilot, which allows companies to collect real-world data through Medicare.

Anita Zielinski will join Cardinal Health in November as its new chief accounting officer.

As Abbott prepares to launch its first dual-analyte sensor, endocrinologists talked to MedTech Dive about considerations for continuous ketone monitoring.

The agency published a discussion paper this week as it considers the “unique risks” and potential promise of generative AI for patient care.

Digital health technologies used in studies should be validated and measure outcomes that matter to patients, the FDA said.

Sondermind and Limbic are evaluating digital health devices intended to help with anxiety and depression.

Abbott plans to roll out the device, called Libre Duo 10 Day, later this year. The sensor can measure both glucose and ketones.

The purchase would give Abbott access to cancer screening tests including Cologuard and blood tests for multi-cancer early detection.

Dexcom CEO Jake Leach said he is watching for a decision by the federal health insurance program before the end of the year.